Tweet
I know that one of Covaris' claims to fame is that their AFA shearing is DNA concentration independent. They have literature showing bioanalyzer traces of identical size distributions obtained from 50ng and 2ug samples. Has anyone tried to shear more than 2ug of DNA in a single treatment? Any thoughts about whether the size distribution will be altered if I try to shear 10ug+ in a single treatment with parameters that were optimized on 1ug samples?
-
-
I have sheared from 1-5000 ng with similar results. Covaris recommendation is for 100-5000 ng. Trial with your DNA is the best way. I would suggest normalising sheared DNA to the same concentration for all samples (if using various concentrations) before Bioanalyser analysis. -
Thanks for the info, nucacidhunter. I did a trial with non-precious gDNA and I got equal shearing using samples containing 1ug and 5ug of DNA (as quantified by picogreen). However, samples containing 10ug and 20ug of DNA ended up with a broad, almost bimodal distribution of fragment sizes.
In the future I'll simply break up my high-mass samples into 5ug chunks and shear each chunk independently. I bead-purify after shearing anyway, so it will be easy to re-concentrate the total fragmented pool.Comment
-
Covaris shearing of DNA is indeed concentration independent. I have attached one customer's data in which they carried out a shearing of 1-50ug of DNA in 130ul volume in a microTUBE.
As Nucacidhunter suggested, I would also advise that you determine a working range of concentration for your samples, and try to keep your samples within that range so as not to bias or adversely effect the efficiency of other steps in your library preparation.
Thank you
hamidComment
-
Also, keep in mind that Covaris has different tubes for different applications. I haven't looked into it specifically for your wants, but you might find a different tube type more accommodating for your needs.Comment
-
I’m not a sequencing expert. I’m a purification scientist who uses NGS to evaluate workflows my group develops. With this perspective, we think about the sample first and the NGS workflow second. The sequencer is an exceptionally honest reporter, but it can only report on what you give it, so whether you get clean, interpretable data from an NGS workflow is largely determined before you begin.
Here are nine questions we think about, in roughly the order they matter, before...Yesterday, 07:11 AM -
Data variability is still an issue in sequencing technologies despite the advances in reproducibility and accuracy of these platforms. But the problem does not originate in the sequencing itself, but in the previous steps, before the sample reaches the sequencer.
The first step is collection, followed by preservation and sample preparation for analysis. Most scientists overlook those steps, but not being careful might just be skewing the experiment’s results.
...06-02-2026, 10:05 AM -
With the launch of new single-cell sequencing platforms in 2026, the field stands at an exciting inflection point. This article surveys the most impactful advances in the field and discusses how they’re reshaping research in cancer, immunology, and beyond.
Introduction
Single-cell sequencing technologies have undergone remarkable advances over the past decade, transitioning from low-throughput experimental approaches to highly scalable platforms capable of...05-22-2026, 06:42 AM
Comment